Abstract
Lipids have gained significant attention in drug delivery systems due to their biocompatibility, ease of functionalization, and ability to encapsulate a wide range of therapeutic agents. Lipid-based carriers such as liposomes, lipid nanoparticles (LNPs), and solid lipid nanoparticles (SLNs) have revolutionized the pharmaceutical industry by offering controlled release, targeted delivery, and enhanced bioavailability. This article explores the advancements in lipid-based drug delivery systems, their mechanisms, applications, and challenges in clinical settings. Current innovations in lipid formulations and their role in personalized medicine are also discussed. These systems hold potential for improving the treatment of various diseases, particularly cancer, viral infections, and neurological disorders.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.